Manuel González-Barón

4.9k total citations · 1 hit paper
55 papers, 3.8k citations indexed

About

Manuel González-Barón is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Manuel González-Barón has authored 55 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Molecular Biology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Manuel González-Barón's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (13 papers) and Genetic factors in colorectal cancer (9 papers). Manuel González-Barón is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (13 papers) and Genetic factors in colorectal cancer (9 papers). Manuel González-Barón collaborates with scholars based in Spain, United States and Italy. Manuel González-Barón's co-authors include Javier de Castro, Cristóbal Belda-Iniesta, Paloma Cejas, Juan Ángel Fresno Vara, E. Casado, Jaime Feliú, Enrique Espinosa, Enrique Casado, Rosário Madero and Miguel Ángel García‐Cabezas and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Manuel González-Barón

54 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PI3K/Akt signalling pathway and cancer

2003 1.9k citations Juan Ángel Fresno Vara, E. Casado et al. Cancer Treatment Reviews profile →

Peers

Countries citing papers authored by Manuel González-Barón

Since Specialization

Citations

This map shows the geographic impact of Manuel González-Barón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel González-Barón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel González-Barón more than expected).

Fields of papers citing papers by Manuel González-Barón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel González-Barón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel González-Barón. The network helps show where Manuel González-Barón may publish in the future.

Co-authorship network of co-authors of Manuel González-Barón

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel González-Barón. A scholar is included among the top collaborators of Manuel González-Barón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel González-Barón. Manuel González-Barón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy 2012 ·Current Cancer Drug Targets ·Paloma Cejas, Miriam López-Gómez, Cristina Aguayo, Rosário Madero, Juan Moreno‐Rubio, (unknown), Cristóbal Belda-Iniesta, Jorge Barriuso, Víctor Moreno, (unknown), (unknown), Manuel González-Barón, Jaime Feliú	34
2	A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer 2011 ·Clinical Cancer Research ·E. Casado, Víctor Moreno, José Javier Sánchez, Montserrat Blanco, Joan Maurel, Jaime Feliú, Carlos Fernández-Martos, Javier de Castro, Beatriz Castelo, Cristóbal Belda-Iniesta, María Sereno, (unknown), Emilio Burgos, Miguel Ángel García‐Cabezas, Noemí Manceñido, Rosa Miquel, Damián García‐Olmo, Manuel González-Barón, Paloma Cejas	25
3	Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study 2011 ·Chemotherapy ·Jaime Feliú Batlle, Elena Cuadrado‐Payán, (unknown), Trinidad Caldés, Cristóbal Belda-Iniesta, Javier Sastre, Jorge Barriuso, (unknown), Eduardo Díaz‐Rubio, Manuel González-Barón	6
4	Development and Validation of a Prognostic Nomogram for Terminally Ill Cancer Patients 2011 ·JNCI Journal of the National Cancer Institute ·Jaime Feliú, (unknown), Rosário Madero, (unknown), Enrique Espinosa, (unknown), (unknown), Beatriz Martínez, Alberto Alonso‐Babarro, Raquel Molina, Juan Carlos Cámara, (unknown), Manuel González-Barón	69
5	KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis 2009 ·PLoS ONE ·Paloma Cejas, Miriam López-Gómez, Cristina Aguayo, Rosário Madero, Javier de Castro, Cristóbal Belda-Iniesta, Jorge Barriuso, Víctor Moreno, J Larrauri, Rocío López, Enrique Casado, Manuel González-Barón, Jaime Feliú	127
6	MKP1 repression is required for the chemosensitizing effects of NF-κB and PI3K inhibitors to cisplatin in non-small cell lung cancer 2009 ·Cancer Letters ·María Cortés-Sempere, Sharmila Chattopadhyay, Ana Rovira, Vanessa Rodríguez‐Fanjul, Cristóbal Belda-Iniesta, (unknown), Paloma Cejas, Rosario Machado-Pinilla, Cristina Manguán-García, Isabel Sánchez‐Pérez, Manuel Nistal, Carmen Moratilla, Javier de Castro, Manuel González-Barón, Joan Albanell, Rosario Perona	23
7	MALDI Profiling of Human Lung Cancer Subtypes 2009 ·PLoS ONE ·Angelo Gámez‐Pozo, Iker Sánchez‐Navarro, Manuel Nistal, Enrique Calvo, Rosário Madero, (unknown), Emilio Camafeita, Javier de Castro, Juan Antonio López, Manuel González-Barón, Enrique Espinosa, Juan Ángel Fresno Vara	28
8	A critical role for choline kinase-α in the aggressiveness of bladder carcinomas 2009 ·Oncogene ·Eva Hernando, Jacinto Sarmentero, Theresa M. Koppie, Cristóbal Belda-Iniesta, (unknown), Paloma Cejas, Choichiro Ozu, Carl Le, José Javier Sánchez, Manuel González-Barón, Jason A. Koutcher, Carlos Cordon‐Cardo, Bernard H. Bochner, Juan Carlos Lacal, Ana Ramı́rez de Molina	51
9	HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence 2008 ·Carcinogenesis ·Ãlvaro D. Ortega, (unknown), Enrique Espinosa, Manuel González-Barón, José M. Cuezva	47
10	Angiogenesis-Related Gene Expression Profile with Independent Prognostic Value in Advanced Ovarian Carcinoma 2008 ·PLoS ONE ·Marta Mendiola, Jorge Barriuso, Andrés Redondo, Adrián Mariño‐Enríquez, Rosário Madero, Enrique Espinosa, Juan Ángel Fresno Vara, Iker Sánchez‐Navarro, Ginés Hernández-Cortes, Pilar Zamora, Elia Pérez‐Fernández, (unknown), Asunción Suárez, José Palacios, Manuel González-Barón, David Hardisson	18
11	Molecular markers in colorectal cancer: genetic bases for a customised treatment 2007 ·Clinical & Translational Oncology ·Enrique Casado, Javier de Castro, Cristóbal Belda-Iniesta, Paloma Cejas, Jaime Feliú, María Sereno, Manuel González-Barón	9
12	Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study 2007 ·The Lancet Oncology ·Ana Ramı́rez de Molina, Jacinto Sarmentero, Cristóbal Belda-Iniesta, Miquel Tarón, (unknown), Paloma Cejas, Marcin Skrzypski, David Gallego‐Ortega, Javier de Castro, Enrique Casado, Miguel Ángel García‐Cabezas, José Javier Sánchez, Manuel Nistal, Rafael Rosell, Manuel González-Barón, Juan Carlos Lacal	130
13	Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells 2007 ·Cancer Biology & Therapy ·Cristóbal Belda-Iniesta, Rosario Perona, Javier de Castro, Paloma Cejas, Enrique Casado, Cristina Manguán-García, Inmaculada Ibañez de Cáceres, Isabel Sánchez‐Pérez, Francisco A. Bernabéu-Andréu, (unknown), Alfredo Aguilera Bazán, (unknown), (unknown), Rosário Madero, Jaime Feliú, María Sereno, Manuel González-Barón	10
14	Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer 2006 ·Cancer Chemotherapy and Pharmacology ·Jaime Feliú, Guillermo Martı́n, Javier de Castro, Anna Sundlöv, (unknown), Enrique Casado, M. Lomas, C. Madroñal, António Galán de Mera, Cristóbal Belda-Iniesta, Manuel González-Barón	5
15	XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer 2006 ·British Journal of Cancer ·Jaime Feliú, Antonieta Salud, P. Escudero, Luis López‐Gómez, Marc Bolaños, António Galán de Mera, (unknown), Alfonso Yubero, Ferrán Losa, Javier de Castro, (unknown), E. Casado, Manuel González-Barón	80
16	Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer 2005 ·British Journal of Cancer ·(unknown), Jaime Feliú, (unknown), Antonieta Salud, J. R. Mel, (unknown), André Pèlegrin, Luis López‐Gómez, María C. Ruiz, Encarnación González‐Flores, (unknown), (unknown), Javier de Castro, Manuel González-Barón	31
17	Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer 2004 ·British Journal of Cancer ·Jaime Feliú, (unknown), Carlos García Girón, (unknown), Emilio Fonseca, Jorge Aparicio, M. Lomas, Luis Antón-Aparicio, (unknown), Manuel González-Barón	16
18	PI3K/Akt signalling pathway and cancer breakdown → 2003 ·Cancer Treatment Reviews ·Juan Ángel Fresno Vara, E. Casado, Javier de Castro, Paloma Cejas, Cristóbal Belda-Iniesta, Manuel González-Barón	1917
19	β-Catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome 2000 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Javier de Castro, Carlos Gamallo, José Palacios, Gema Moreno‐Bueno, Núria Rodríguez, Jaime Feliú, Manuel González-Barón	39
20	Acute leukemia and pregnancy 1988 ·Cancer ·Jaime Feliú, Silvia Juárez, A. Ordóñez, (unknown), Manuel González-Barón, (unknown)	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact